The Lancet Oncology, October 2011, Volume 12, Issue 11, Pages 981-1080
Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment - The Lancet Oncology
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China - The Lancet Oncology
eBioMedicine Home Page
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study - The Lancet Oncology
The Lancet Oncology | Journal | ScienceDirect.com by Elsevier
Updated 2023) New JCR Impact Factor 2022 – (PDF) – Journal Impact Factor
The Lancet Oncology, August 2012, Volume 13, Issue 8, Pages 743-848, e324-e369
Lancet Oncology, The Impact Factor: scientometric analysis | Exaly
The Lancet Regional Health – Americas
Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study - The Lancet Oncology
The Lancet Regional Health - Europe: Home Page
Oncology - Q1 Journal list | Ali Guner
The Lancet Digital Health
The Lancet Oncology, December 2016, Volume 17, Issue 12, Pages 1621-1754, e515-e568
Lancet Oncology, The
The Lancet Oncology | Journal | ScienceDirect.com by Elsevier
Integration of oncology and palliative care: a Lancet Oncology Commission - The Lancet Oncology
The Lancet Oncology, February 2022, Volume 23, Issue 2, Pages 185-316, e45-e88
Cancer in sub-Saharan Africa: a Lancet Oncology Commission - The Lancet Oncology
Medical imaging and nuclear medicine: a Lancet Oncology Commission - The Lancet Oncology
Exhibition reviewed in Lancet Oncology | Zachary Peirce
The Lancet more than doubles its impact factor, eclipsing NEJM for the first time ever – Retraction Watch
The Lancet Oncology
